To mark World Alzheimer’s Day on 21 September, Drug Discovery World speaks to biotech companies and investors at the forefront of next-generation dementia drugs. After years of trudging through something akin to a Slough of Despond, dementia researchers, clinicians and patients have finally been given something to lift them. The approval of two disease-modifying treatments […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!